Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Prohaska, Thomas A ^a   Wahlmüller, Felix C ^a   Furtmüller, Margareta ^a   Geiger, Margarethe ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; ENTEROPEPTIDASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; TRYPSIN;

ARTICLE; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN INTERACTION; STOICHIOMETRY; WESTERN BLOTTING;

ANIMALS; ANTITHROMBINS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROPEPTIDASE; HEPARIN; HUMANS; MICE; PROTEIN BINDING; PROTEIN C INHIBITOR; SERINE PROTEINASE INHIBITORS; SERPINS;

EID: 84862579844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039262     Document Type: Article

References (56)

1. Marlar RA, Griffin JH, (1980) Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 66: 1186-1189.
2. Suzuki K, Nishioka J, Hashimoto S, (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258: 163-168.
3. Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, et al. (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27: 4231-4237.
4. Espana F, Berrettini M, Griffin JH, (1989) Purification and characterization of plasma protein C inhibitor. Thromb Res 55: 369-384.
5. Geiger M, Huber K, Wojta J, Stingl L, Espana F, et al. (1989) Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. Blood 74: 722-728.
6. Ecke S, Geiger M, Resch I, Jerabek I, Sting L, et al. (1992) Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein. J Biol Chem 267: 7048-7052.
7. Espana F, Estelles A, Fernandez PJ, Gilabert J, Sanchez-Cuenca J, et al. (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 70: 989-994.
8. Zheng X, Geiger M, Ecke S, Bielek E, Donner P, et al. (1994) Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am J Physiol 267: C466-472.
9. Hermans JM, Jones R, Stone SR, (1994) Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry 33: 5440-5444.
10. Cooper ST, Church FC, (1995) Reactive site mutants of recombinant protein C inhibitor. Biochim Biophys Acta 1246: 29-33.
11. Luo LY, Jiang W, (2006) Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Biol Chem 387: 813-816.
12. Fortenberry YM, Brandal S, Bialas RC, Church FC, (2010) Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration. Biochim Biophys Acta 1800: 580-590.
13. Gettins PGW, (2002) Serpin structure, mechanism, and function. Chem Rev 102: 4751-4804.
14. Huntington JA, Li W, (2009) Structural insights into the multiple functions of protein C inhibitor. Cell Mol Life Sci 66: 113-121.
15. Shirk RA, Elisen MG, Meijers JC, Church FC, (1994) Role of the H helix in heparin binding to protein C inhibitor. J Biol Chem 269: 28690-28695.
16. Suzuki K, (2008) The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis. J Thromb Haemost 6: 2017-2026.
17. Ecke S, Geiger M, Binder BR, (1997) Heparin binding of protein-C inhibitor-analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein. Eur J Biochem 248: 475-480.
18. Huntington JA, (2006) Shape-shifting serpins-advantages of a mobile mechanism. Trends Biochem Sci 31: 427-435.
19. Hayashi T, Nishioka J, Kamada H, Asanuma K, Kondo H, et al. (2004) Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost 2: 949-961.
20. Zechmeister-Machhart M, Hufnagl P, Uhrin P, Xu J, Geiger M, et al. (1996) Molecular cloning and tissue distribution of mouse protein C inhibitor (PCI). Immunopharmacology 32: 96-98.
21. Radtke KP, Fernández JA, Greengard JS, Boettger T, Loskutoff DJ, et al. (1996) Pancreatic Protein C Inhibitor. Abstract Book International Symposium on the Chemistry and Biology of Serpins Chapel Hill, NC, USA.
22. Krebs M, Uhrin P, Vales A, Prendes-Garcia MJ, Wojta J, et al. (1999) Protein C inhibitor is expressed in keratinocytes of human skin. J Invest Dermatol 113: 32-37.
23. Zhang C, Li X, Lian X, Wang Y, Zeng Y, et al. (2007) Immunolocalization of protein C inhibitor in differentiation of human epidermal keratinocytes. Acta Histochem 109: 461-467.
24. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H, (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 89: 1094-1101.
25. Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, et al. (2007) Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity. Int J Cancer 121: 955-965.
26. Cao Y, Becker C, Lundwall A, Christensson A, Gadaleanu V, et al. (2003) Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues. Prostate 57: 196-204.
27. Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, et al. (2004) Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 108: 516-523.
28. Sieben NL, Oosting J, Flanagan AM, Prat J, Roemen GM, et al. (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J Clin Oncol 23: 7257-7264.
29. Bijsmans IT, Smits KM, de Graeff P, Wisman GB, van der Zee AG, et al. (2011) Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. Mod Pathol 24: 463-470.
30. Hobson JP, Netzel-Arnett S, Szabo R, Rehault SM, Church FC, et al. (2004) Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. J Biol Chem 279: 46981-46994.
31. Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM, Bugge TH, (2005) Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity. Biochem J 390: 231-242.
32. Imamura T, Kitamoto Y, (2003) Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum. Am J Physiol Gastrointest Liver Physiol 285: G1235-1241.
33. Zheng XL, Kitamoto Y, Sadler JE, (2009) Enteropeptidase, a type II transmembrane serine protease. Front Biosci (Elite Ed) 1: 242-249.
34. Lu D, Yuan X, Zheng X, Sadler JE, (1997) Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J Biol Chem 272: 31293-31300.
35. Fernandez-del Castillo C, Schmidt J, Warshaw AL, Rattner DW, (1994) Interstitial protease activation is the central event in progression to necrotizing pancreatitis. Surgery 116: 497-504.
36. Reiser J, Adair B, Reinheckel T, (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120: 3421-3431.
37. McCutcheon AD, (2000) Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis. Arch Surg 135: 278-285.
38. Nakanishi J, Yamamoto M, Koyama J, Sato J, Hibino T, (2010) Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation. J Invest Dermatol 130: 944-952.
39. Vilen ST, Nyberg P, Hukkanen M, Sutinen M, Ylipalosaari M, et al. (2008) Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res 314: 914-926.
40. Cottrell GS, Amadesi S, Grady EF, Bunnett NW, (2004) Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 279: 13532-13539.
41. Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M, et al. (1991) Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. Cancer Res 51: 2107-2112.
42. Lukkonen A, Sorsa T, Salo T, Tervahartiala T, Koivunen E, et al. (2000) Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: association with reduced cancer cell migration. Int J Cancer 86: 577-581.
43. Malleier JM, Oskolkova O, Bochkov V, Jerabek I, Sokolikova B, et al. (2007) Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids. Blood 109: 4769-4776.
44. Schechter NM, Plotnick MI, (2004) Measurement of the kinetic parameters mediating protease-serpin inhibition. Methods 32: 159-168.
45. Hermans JM, Stone SR, (1993) Interaction of activated protein C with serpins. Biochem J 295 (Pt 1): 239-245.
46. Geiger M, (2007) Protein C inhibitor, a serpin with functions in- and outside vascular biology. Thromb Haemost 97: 343-347.
47. Li W, Huntington JA, (2008) The heparin binding site of protein C inhibitor is protease-dependent. J Biol Chem 283: 36039-36045.
48. Pratt CW, Church FC, (1992) Heparin binding to protein C inhibitor. J Biol Chem 267: 8789-8794.
49. Hooper JD, Clements JA, Quigley JP, Antalis TM, (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276: 857-860.
50. Matsushima M, Ichinose M, Yahagi N, Kakei N, Tsukada S, et al. (1994) Structural characterization of porcine enteropeptidase. J Biol Chem 269: 19976-19982.
51. Fonseca P, Light A, (1982) Incorporation of bovine enterokinase into synthetic phospholipid vesicles. Biophys J 37: 44-45.
52. Vonlaufen A, Wilson JS, Apte MV, (2008) Molecular mechanisms of pancreatitis: current opinion. J Gastroenterol Hepatol 23: 1339-1348.
53. Bungum M, Giwercman A, Bungum L, Humaidan P, Rastkhani H, et al. (2010) Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure. Fertil Steril 93: 277-279.
54. Meyer-Hoffert U, (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp (Warsz) 57: 345-354.
55. Rehault SM, Zechmeister-Machhart M, Fortenberry YM, Malleier J, Binz NM, et al. (2005) Characterization of recombinant human protein C inhibitor expressed in Escherichia coli. Biochim Biophys Acta 1748: 57-65.
56. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.